Related Experiment Videos
Induction of programmed cell death with an antisense Bcl-2 oligonucleotide
Patrick P Koty1, Wendong Lei, Mark L Levitt
1Department of Environmental and Occupational Health, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Methods in Molecular Medicine
|November 1, 2002
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Phase II trial of neoadjuvant camrelizumab and apatinib in resectable NSCLC: 3-year survival outcomes and dynamic circulating tumor DNA analyses.
European journal of cancer (Oxford, England : 1990)·2026
Nance-Horan Syndrome: Further Delineation of the Affected Male and the Female Carrier Phenotypes.
American journal of medical genetics. Part A·2025
Recent Progress in the Development of Opaganib for the Treatment of Covid-19.
Drug design, development and therapy·2022
Opaganib in Coronavirus Disease 2019 Pneumonia: Results of a Randomized, Placebo-Controlled Phase 2a Trial.
Open forum infectious diseases·2022
Methods for cancer gene therapy using tumor suppressor genes.
Methods in molecular medicine·2014
Suppression of the human carcinoma phenotype by an antioncogene ribozyme.
Methods in molecular medicine·2014
Methods for the use of stromal cells for therapeutic gene therapy.
Methods in molecular medicine·2014
Methods for adenovirus-mediated gene transfer to synovium in vivo.
Methods in molecular medicine·2014
Methods for gene transfer to synovium.
Methods in molecular medicine·2014
Methods for generation of genetically modified fibroblasts for immunotherapy of cancer.
Methods in molecular medicine·2014
BRIGHTLINE-1: When a Negative Trial Reveals Two Active Therapies.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
The pan-tumor landscape, allelic status, and genomic complexity of SMARCA4 alterations.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
CAR T Cells Targeting an Intracellular Leukemia Antigen Promiscuously Presented by Diverse HLA-II Alleles.
Blood cancer discovery·2026
Impact of GAD-65 Antibody Detection on Antihyperglycemic Therapy in T2D.
Endocrine connections·2026